Bexion Pharmaceuticals
Dr. Tesi has a distinguished career as a biotech entrepreneur and an experienced surgeon. Currently, he is President, Chief Executive Officer and acting Chief Medical Officer of INmune Bio (NASDAQ: INMB). Prior to his role at INMB, he held leadership positions in several biotech companies in both the development and commercial sides of the businesses with responsibility for all phases of drug development, product positioning and launch, post-approval marketing support, while supporting investor relations and business development. Dr. Tesi has been an academic transplant surgeon since 1982, receiving his MD degree from Washington University School of Medicine, and has been a Fellow of the American College of Surgery since 1991.
This person is not in the org chart
This person is not in any offices
Bexion Pharmaceuticals
Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. Bexion focuses on helping patients and their families living with cancer, where there is a significant unmet need.